Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Humar

Showing results (131-140 of 235) with videos related to

Pageof 24
Sort By:
Plos One|April 18, 2013
Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasmaHalvor Rollag, Thor Ueland, Anders Asberg, et al.
Transplantation|June 28, 2003
Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled studyShahid Husain, Jan Tollemar, Edward A Dominguez, et al.
Transplantation|October 30, 2012
Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcomeHalvor Rollag, Anders Asberg, Thor Ueland, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 23, 2021
Natural influenza infection produces a greater diversity of humoral responses than vaccination in immunosuppressed transplant recipientsCedric Hirzel, Andrzej Chruscinski, Victor H Ferreira, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
A surveillance study of adenovirus infection in adult solid organ transplant recipientsAtul Humar, Deepali Kumar, Tony Mazzulli, et al.
The Journal of Infectious Diseases|November 5, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Induces Greater T-Cell Responses Compared to Vaccination in Solid Organ Transplant RecipientsVictor H Ferreira, Tina Marinelli, Matthew Ierullo, et al.
Plos Pathogens|April 14, 2017
Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infectionJessica Rose, Vincent C Emery, Deepali Kumar, et al.
Plos Pathogens|May 11, 2017
Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infectionJessica Rose, Vincent C Emery, Deepali Kumar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2013
Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipientsRaymund R Razonable, Anders Åsberg, Halvor Rollag, et al.
Transplantation|April 9, 2025
The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ TransplantationCamille N Kotton, Deepali Kumar, Oriol Manuel, et al.
Pageof 24

Showing results (131-140 of 235) with videos related to

Sort By:
Pageof 24
Plos One|April 18, 2013
Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasmaHalvor Rollag, Thor Ueland, Anders Asberg, et al.
Transplantation|June 28, 2003
Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled studyShahid Husain, Jan Tollemar, Edward A Dominguez, et al.
Transplantation|October 30, 2012
Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcomeHalvor Rollag, Anders Asberg, Thor Ueland, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 23, 2021
Natural influenza infection produces a greater diversity of humoral responses than vaccination in immunosuppressed transplant recipientsCedric Hirzel, Andrzej Chruscinski, Victor H Ferreira, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
A surveillance study of adenovirus infection in adult solid organ transplant recipientsAtul Humar, Deepali Kumar, Tony Mazzulli, et al.
The Journal of Infectious Diseases|November 5, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Induces Greater T-Cell Responses Compared to Vaccination in Solid Organ Transplant RecipientsVictor H Ferreira, Tina Marinelli, Matthew Ierullo, et al.
Plos Pathogens|April 14, 2017
Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infectionJessica Rose, Vincent C Emery, Deepali Kumar, et al.
Plos Pathogens|May 11, 2017
Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infectionJessica Rose, Vincent C Emery, Deepali Kumar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2013
Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipientsRaymund R Razonable, Anders Åsberg, Halvor Rollag, et al.
Transplantation|April 9, 2025
The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ TransplantationCamille N Kotton, Deepali Kumar, Oriol Manuel, et al.
Pageof 24